Breast & Ovarian Cancer Screening | NYU Langone Health
At NYU Langone’s Perlmutter Cancer Center, we offer screening and special high-risk programs for breast and ovarian cancer.
Breast Cancer | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center use sophisticated technologies to diagnose and treat women with breast cancer.
Breast Cancer Center | NYU Langone Health
Experts at NYU Langone’s Breast Cancer Center use the latest techniques and technology to treat all stages and types of breast cancer.
Breast Cancer Diagnosis | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center use the results of imaging, biopsy, and tissue tests to diagnose breast cancer.
Breast Cancer Screening | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center offer breast cancer screening options, including mammograms, ultrasounds, and MRI scans.
Breast Imaging at NYU Langone Ambulatory Surgery Center—Garden City | NYU Langone Health
Breast Imaging at NYU Langone Ambulatory Surgery Center—Garden City provides bone density testing, breast ultrasound, and mammography.
Breast Plastic Surgery Services | NYU Langone Health
Plastic surgeons at NYU Langone perform technologically sophisticated reconstructive and cosmetic breast surgery.
Breast Reconstruction for Breast Cancer | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center may use breast reconstruction techniques after mastectomy or lumpectomy for breast cancer.
Bret J. Rudy, MD | NYU Langone Health
Bret J. Rudy, MD, is vice president and chief of hospital operations at NYU Langone Hospital—Brooklyn.
Bringing the DPP to Geriatric Populations
Over 24 million Americans are =65 years and have prediabetes. Prediabetes can be addressed using a public health approach: among the 20% of participants in the Diabetes Prevention Program (DPP) who were ages 60 and over, the diet and physical activity intervention conferred a 71% risk reduction of diabetes after an average follow-up of 3 years. The population of older adults is projected to more than double from 52.5 million in 2019 to ~100 million by 2060, and if projections hold, about half (48.3%) will have prediabetes. The proposed hybrid effectiveness implementation type 1 design will compare a DPP program Tailored for Older Adults and delivered via Telehealth (DPP-TOAT arm) to an in person DPP tailored for older adults (DPP arm) using a randomized, controlled trial design (n=230). Innovation: Our preliminary data suggests DPP-TOAT is a feasible and acceptable way to deliver the DPP to older adults, and this will be the first study to compare the effectiveness and implementation of two strategies (telehealth versus in-person) to deliver a tailored DPP for the unique needs of the growing population of older adults. Eligible patients will be recruited through electronic health records (Epic and MyChart) and randomized to the 12-month DPP-TOAT or the in-person DPP program. Primary effectiveness outcome will be 6-month weight loss and implementation outcome will be attendance. We will use a pragmatic approach in order to inform future studies conducted in community-based and rural settings. Findings will inform best practices in the delivery of an evidence-based intervention that could reach the 30+ million adults aged 65 and over with prediabetes.